An industry-first fully-integrated fraud, waste, and abuse solution.

Pharmaceutical commercialization is shaped by dynamic interactions between pricing, access, and patient behavior. This creates a complex environment where drivers of financial performance are affected by many constantly changing variables. It can be difficult to understand the true drivers of growth and profitability, limiting visibility into how sales performance, access investments, and gross-to-net (GTN) dynamics […]

Traditional hub services often struggle to balance operational efficiency with patient access.

A third-to-market brand in a $10B+ therapeutic area needed to improve the impact of its sales force but lacked the tools and insights to know where to focus.

Copay programs are often viewed as just an investment in patient access rather than a source of strategic insights. At Apollo Care, we asked why both cannot be true?

Apollo Care’s advanced solutions were designed to address rising Gross-to-Net (GTN) costs so that manufacturers can continue to invest in patient access and affordability while also balancing pressure to reduce GTN.

The acquisition of eStrat, a copay program provider, expands our copay portfolio and enables new product opportunities, strengthening our ability to deliver high-impact affordability solutions.

We’re proud to announce Apollo Care’s partnership with the UChicago Data Science Institute! Together, we’re leveraging cutting-edge innovation to improve patient access & affordability while driving meaningful change across the healthcare ecosystem.

Apollo Care is happy to partner with Harrow to support the VEVYE® Access for All program, expanding patient access through our specialty pharmacy solutions.

Our acquisition of Scripts Rx’s pharmacy platform will enhance and expand market offerings for complex and specialty medications by leveraging a suite of tech-enabled patient service and care-coordination portals.

Apollo Care’s innovative approach to patient access was featured on the latest episode of Advancements with Ted Danson, which explores state-of-the-art technologies and solutions dedicated to shaping and transforming our world.

We’re incredibly proud to partner with Flexpoint Ford to accelerate our innovation and growth strategy. Thanks to our incredible team for all the hard work and ingenuity. We’re excited for the next chapter!

Our acquisition of Truveris Life Sciences is now complete. The acquisition immediately enhances our ability to deliver copay, rebate, and affordability solutions at scale and adds advanced analytics tools and program infrastructure.